Showing 1 to 2 of 2 results


Sandoz CEO Rejects US Tariffs, Prioritizes European Investment
Sandoz CEO Richard Saynor criticizes US pharmaceutical tariffs, citing their counterproductive impact on investment and advocating for stronger regulations on originator companies to foster competition. Sandoz is instead heavily investing in Slovenia, exceeding \$1.1 billion by 2029.
Sandoz CEO Rejects US Tariffs, Prioritizes European Investment
Sandoz CEO Richard Saynor criticizes US pharmaceutical tariffs, citing their counterproductive impact on investment and advocating for stronger regulations on originator companies to foster competition. Sandoz is instead heavily investing in Slovenia, exceeding \$1.1 billion by 2029.
Progress
40% Bias Score

French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.

French Court Awards €325,000 for Androcur's Failure to Warn of Meningioma Risk
A French court ordered Bayer, Viatris, and Sandoz to pay €325,000 to a woman who developed meningiomas after taking Androcur for over 20 years due to their failure to adequately warn her about this risk, a ruling that could affect future legal actions.
Progress
40% Bias Score
Showing 1 to 2 of 2 results